Guo Z, Li H, Jiang S, Rahmati M, Su J, Yang S
Bone Joint Res. 2025; 14(3):185-198.
PMID: 40036085
PMC: 11878473.
DOI: 10.1302/2046-3758.143.BJR-2024-0252.R1.
Shareef Mahmood N, Mahmood A, Maulood I
Cytotechnology. 2025; 77(2):55.
PMID: 39927136
PMC: 11799518.
DOI: 10.1007/s10616-025-00720-y.
Tsubokawa D
Front Parasitol. 2025; 1():1091596.
PMID: 39816467
PMC: 11731691.
DOI: 10.3389/fpara.2022.1091596.
Cross K, Vetter S, Alam Y, Hasan M, Nath A, Leclerc E
Biomolecules. 2025; 14(12.
PMID: 39766257
PMC: 11673996.
DOI: 10.3390/biom14121550.
Semchyshyn H
Front Nutr. 2024; 11:1500375.
PMID: 39698244
PMC: 11652219.
DOI: 10.3389/fnut.2024.1500375.
Are the Soluble Receptors sRAGE, sRANKL, and Osteoprotegerin Associated with Anemia in Rheumatoid Arthritis?.
Stefanova K, Delcheva G, Stankova T
Int J Mol Sci. 2024; 25(23).
PMID: 39684440
PMC: 11640924.
DOI: 10.3390/ijms252312729.
Models of Diabetes: Focus on Diabetic Retinopathy.
Galgani G, Bray G, Martelli A, Calderone V, Citi V
Cells. 2024; 13(22).
PMID: 39594613
PMC: 11592768.
DOI: 10.3390/cells13221864.
In vivo glycation-interplay between oxidant and carbonyl stress in bone.
Sroga G, Vashishth D
JBMR Plus. 2024; 8(11):ziae110.
PMID: 39386996
PMC: 11458925.
DOI: 10.1093/jbmrpl/ziae110.
Role of Receptor for Advanced Glycation End-Products in Endometrial Cancer: A Review.
Zglejc-Waszak K, Jozwik M, Thoene M, Wojtkiewicz J
Cancers (Basel). 2024; 16(18).
PMID: 39335163
PMC: 11430655.
DOI: 10.3390/cancers16183192.
Combined therapeutic strategy based on blocking the deleterious effects of AGEs for accelerating diabetic wound healing.
Yang Y, Huang S, Ma Q, Li N, Li R, Wang Y
Regen Biomater. 2024; 11:rbae062.
PMID: 39323743
PMC: 11424028.
DOI: 10.1093/rb/rbae062.
Ultrasound-Assisted Synthesis of Pyrazoline Derivatives as Potential Antagonists of RAGE-Mediated Pathologies: Insights from SAR Studies and Biological Evaluations.
Dascalu A, Furman C, Lancel S, Lipka E, Liberelle M, Boulanger E
ChemMedChem. 2024; 20(1):e202400527.
PMID: 39289154
PMC: 11694609.
DOI: 10.1002/cmdc.202400527.
Advanced Glycation End-Products Acting as Immunomodulators for Chronic Inflammation, Inflammaging and Carcinogenesis in Patients with Diabetes and Immune-Related Diseases.
Shen C, Lu C, Cheng C, Li K, Kuo Y, Wu C
Biomedicines. 2024; 12(8).
PMID: 39200164
PMC: 11352041.
DOI: 10.3390/biomedicines12081699.
Cell Proliferation and Apoptosis-Key Players in the Lung Aging Process.
Ancer-Rodriguez J, Gopar-Cuevas Y, Garcia-Aguilar K, Chavez-Briones M, Miranda-Maldonado I, Ancer-Arellano A
Int J Mol Sci. 2024; 25(14).
PMID: 39063108
PMC: 11276691.
DOI: 10.3390/ijms25147867.
HMGB1 as an extracellular pro-inflammatory cytokine: Implications for drug-induced organic damage.
Yuan J, Guo L, Ma J, Zhang H, Xiao M, Li N
Cell Biol Toxicol. 2024; 40(1):55.
PMID: 39008169
PMC: 11249443.
DOI: 10.1007/s10565-024-09893-2.
Differential Rates of Glycation Following Exposure to Unique Monosaccharides.
Clarke D, Koutnik A, Johnson R, DeBlasi J, Bikman B, Arroyo J
Int J Mol Sci. 2024; 25(13).
PMID: 39000037
PMC: 11240907.
DOI: 10.3390/ijms25136921.
Effects of protein glycation and protective mechanisms against glycative stress.
Najjar J, Calvert J
Curr Opin Pharmacol. 2024; 76:102464.
PMID: 38796877
PMC: 11229435.
DOI: 10.1016/j.coph.2024.102464.
Clinical Phenotypes, Serological Biomarkers, and Synovial Features Defining Seropositive and Seronegative Rheumatoid Arthritis: A Literature Review.
Perera J, Delrosso C, Nerviani A, Pitzalis C
Cells. 2024; 13(9.
PMID: 38727279
PMC: 11083059.
DOI: 10.3390/cells13090743.
Advanced Glycation End Products and Health: A Systematic Review.
Zhu J, Wang Z, Lv C, Li M, Wang K, Chen Z
Ann Biomed Eng. 2024; 52(12):3145-3156.
PMID: 38705931
DOI: 10.1007/s10439-024-03499-9.
Major endothelial damage markers identified from hemadsorption filters derived from treated patients with septic shock - endoplasmic reticulum stress and bikunin may play a role.
Kasper R, Rodriguez-Alfonso A, Standker L, Wiese S, Schneider E
Front Immunol. 2024; 15:1359097.
PMID: 38698864
PMC: 11063272.
DOI: 10.3389/fimmu.2024.1359097.
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.
Ribaric S
Int J Mol Sci. 2024; 25(8).
PMID: 38673943
PMC: 11050090.
DOI: 10.3390/ijms25084358.